Study: Public messaging should be communicated before the availability of COVID-19 vaccines

NewsGuard 100/100 Score

A new study indicates some significant public messaging should be communicated before any COVID-19 vaccines are made available in the US. And with vaccines potentially being approved by the end of the year or early next year, the clock is ticking.

The report, published in the journal Vaccines, shows that 68% of respondents are supportive of being vaccinated for COVID-19, but concerns remain about side effects, sufficient vaccine testing and vaccine effectiveness.

Messages promoting the COVID-19 vaccine need to alleviate the concerns of those who are already vaccine-hesitant. Vaccine hesitancy is growing and the World Health Organization has already deemed it one of the top threats to global health."

Brian Poole, Study Senior Author and Professor, Microbiology and Molecular Biology, Brigham Young University

According to the study, there were two factors that most strongly predicted attitudes toward getting a COVID-19 vaccine:

How people feel about vaccines in general: If people are generally pro vaccine, they are generally pro COVID-19 vaccine. How much of a challenge people believe the pandemic is for America: Respondents who said the pandemic was a severe problem for America were much more likely to want to be vaccinated for COVID-19.

Perhaps surprisingly in today's current climate, the researchers found no causal relationship between political ideology and attitudes toward the COVID-19 vaccine.

"Public health messaging regarding COVID-19 vaccination should be less about the individual need for vaccination and more about the country and how to get it back to where it needs to be," Poole said. "It also needs to address vaccine hesitancy head on and demonstrate how vaccines are safe."

The study also concludes that enough time should be taken to address concerns about both short- and long-term side effects before a vaccine is released.

According to previous research, roughly 10% of Americans are anti-vaccine (meaning they refuse to get vaccinated under any circumstance), but a growing number are vaccine-hesitant, roughly 10-25%. Vaccine hesitant individuals tend to want to "spread out vaccinations" and say they will get vaccinated for some diseases, but not all of them.

The current study survey was administered to respondents across the United States, with participants selected by age, race and sex to reflect national census data. Structural Equation Modeling was used to analyze the relationships of several factors with attitudes toward potential COVID-19 vaccination.

"It is critical that we understand the potential barriers to vaccine uptake prior to the release of a COVID vaccine," said study coauthor Jamie Jensen, BYU professor of biology.

"By understanding these barriers, we can design publicity strategies that will speak directly to the potential issues and hopefully get out ahead of any public dissent. With a vaccine being the most powerful weapon we have to end this global pandemic, the knowledge from this study is absolutely critical."

Journal reference:

Pogue, K., et al. (2020) Influences on Attitudes Regarding Potential COVID-19 Vaccination in the United States. Vaccines.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Pioneering vaccine strategy promises to outmaneuver antimicrobial resistance